Boston Scientific S-ICD® System Named Most Innovative Product at Cardiostim 2012 |
Boston Scientific Corp.
One Boston Scientific Place
Natick, MA, 01760
USA
Press release date: July 2, 2012
PARIS, - S-ICDŽ System selected as most innovative in the field of Electrophysiology and Cardiac Techniques
Attendees of Cardiostim 2012, a global medical conference held recently in Nice, France, have selected the S-ICDŽ System recently acquired by Boston Scientific Corporation (NYSE: BSX) as the most innovative product in the sector of Electrophysiology and Cardiac Techniques.
Cardiostim conducted a survey among the 5,600 conference attendees to select the industry's most innovative products or services.
"We are very proud of this recognition which shows the interest and appreciation of the S-ICD System in the EP community," said Pierre Chauvineau, vice president and general manager of Boston Scientific's international S-ICD team.
"The Innovation Award validates our view that the S-ICD System represents a truly revolutionary and ground-breaking new option for patients," said Michael Onuscheck, senior vice president and president of Boston Scientific EMEA.
Cameron Health, Inc. developed the world's first and only commercially available subcutaneous (below the skin) implantable cardioverter defibrillator - the S-ICD System - which is an important new therapy alternative for patients at risk of sudden cardiac arrest. Boston Scientific acquired the S-ICD System when it completed its acquisition of Cameron Health earlier this month.
Unlike conventional implantable cardioverter defibrillators (ICDs), which require thin, insulated wires (leads) to pass through the venous system and into the heart, the entire S-ICD System sits just below the skin and leaves the heart and blood vessels untouched.
The S-ICD System received CE Mark in 2009 and is commercially available in many countries in Europe, as well as New Zealand. In the United States, the S-ICD System is currently under review for approval by the Food and Drug Administration. It is limited under U.S. law to investigational use only, and is not available for sale in the U.S.
For more news about Boston Scientific, please follow us on Twitter @bsc_eu_heart https://twitter.com/#!/BSC_EU_Heart
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.
Source: Boston Scientific Corporation
CONTACT: Geraldine Varoqui, +491707828558 (mobile), Media Relations EMEA, Boston Scientific Corporation, geraldine.varoqui@bsci.com
|
User comments about this story
Principal
Send postal address for head of new defibrillator.
By Don Casey Dynatron Research on Oct 6, 2012 11:56
Reply to this comment
|
|
|
See related product stories
|
|
|
|
|
|
|
|
|
|
